{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:37:31Z","timestamp":1777941451473,"version":"3.51.4"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:00:00Z","timestamp":1777680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent a major advancement in obesity treatment, offering robust efficacy in weight loss and metabolic regulation. Beyond these effects, emerging evidence indicates that GLP-1 RAs also modulate appetite, reward sensitivity, and self-regulation, domains that intersect with behavioral and psychological functioning. This review adopts a biopsychosocial perspective to examine how GLP-1 RAs interact with eating behavior, mood, identity, and self-regulation, particularly in individuals with binge eating disorder (BED) or other psychiatric comorbidities. A clinical framework is proposed to integrate pharmacotherapy with lifestyle and psychological interventions. The temporary reduction in appetite and food reward may create a \u201clow-drive window\u201d in which behavioral strategies such as self-monitoring or stimulus control become more effective. However, high emotional eating, mood symptoms, or identity conflicts may moderate treatment response. Given the high prevalence of psychiatric comorbidities, structured screening using tools like the Patient Health Questionnaire-9 (PHQ-9) or Binge Eating Scale (BES) is recommended. A stepped-care approach from brief digital interventions to formal psychotherapy may help address varying support needs. Crucially, weight regain after discontinuation is common. The review discusses behavioral, psychological, and social mechanisms of relapse and highlights strategies for long-term stabilization. These include emotion regulation, body image work, and maintenance-focused behavioral interventions. GLP-1 RAs should therefore be seen not as standalone treatments but as facilitators of self-directed, sustainable change within integrated care models. Future research should define composite outcomes, explore digital tools for relapse prevention, and develop adaptive pathways tailored to individual psychological profiles.<\/jats:p>","DOI":"10.1007\/s11154-026-10047-4","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:24:38Z","timestamp":1777703078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond weight loss: Integrating GLP-1 RA therapies into psychological and behavioral care for obesity and binge eating disorder"],"prefix":"10.1007","author":[{"given":"Isa","family":"Mack","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kullmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Le Morvan de Sequeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bea","family":"Klos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Erschens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,2]]},"reference":[{"issue":"7","key":"10047_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/obr.12551","volume":"18","author":"GA Bray","year":"2017","unstructured":"Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715\u201323. https:\/\/doi.org\/10.1111\/obr.12551.","journal-title":"Obes Rev"},{"issue":"1","key":"10047_CR2","doi-asserted-by":"publisher","first-page":"205510291663436","DOI":"10.1177\/2055102916634364","volume":"3","author":"DL Rosenbaum","year":"2016","unstructured":"Rosenbaum DL, White KS. Understanding the complexity of biopsychosocial factors in the public health epidemic of overweight and obesity. Health Psychol Open. 2016;3(1):2055102916634364. https:\/\/doi.org\/10.1177\/2055102916634364.","journal-title":"Health Psychol Open"},{"issue":"20","key":"10047_CR3","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M. Obesity management in adults: a review. JAMA. 2023;330(20):2000\u201315. https:\/\/doi.org\/10.1001\/jama.2023.19897.","journal-title":"JAMA"},{"issue":"1","key":"10047_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41398-023-02447-w","volume":"13","author":"M Leutner","year":"2023","unstructured":"Leutner M, Dervic E, Bellach L, Klimek P, Thurner S, Kautzky A. Obesity as pleiotropic risk state for metabolic and mental health throughout life. Transl Psychiatry. 2023;13(1):175. https:\/\/doi.org\/10.1038\/s41398-023-02447-w.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10047_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-022-00344-y","volume":"8","author":"KE Giel","year":"2022","unstructured":"Giel KE, Bulik CM, Fernandez-Aranda F, Hay P, Keski-Rahkonen A, Schag K, et al. Binge eating disorder. Nat Rev Dis Primers. 2022;8(1):16. https:\/\/doi.org\/10.1038\/s41572-022-00344-y.","journal-title":"Nat Rev Dis Primers"},{"key":"10047_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cpr.2017.09.004","volume":"58","author":"AI Heriseanu","year":"2017","unstructured":"Heriseanu AI, Hay P, Corbit L, Touyz S. Grazing in adults with obesity and eating disorders: a systematic review of associated clinical features and meta-analysis of prevalence. Clin Psychol Rev. 2017;58:16\u201332. https:\/\/doi.org\/10.1016\/j.cpr.2017.09.004.","journal-title":"Clin Psychol Rev"},{"key":"10047_CR7","doi-asserted-by":"publisher","first-page":"766827","DOI":"10.3389\/fpsyg.2021.766827","volume":"12","author":"J Kaur","year":"2021","unstructured":"Kaur J, Dang AB, Gan J, An Z, Krug I. Night eating syndrome in patients with obesity and binge eating disorder: a systematic review. Front Psychol. 2021;12:766827. https:\/\/doi.org\/10.3389\/fpsyg.2021.766827.","journal-title":"Front Psychol"},{"issue":"6","key":"10047_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11892-018-1000-x","volume":"18","author":"T van Strien","year":"2018","unstructured":"van Strien T. Causes of emotional eating and matched treatment of obesity. Curr Diab Rep. 2018;18(6):35. https:\/\/doi.org\/10.1007\/s11892-018-1000-x.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10047_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/erv.2906","volume":"30","author":"HSJ Chew","year":"2022","unstructured":"Chew HSJ, Lau ST, Lau Y. Weight-loss interventions for improving emotional eating among adults with high body mass index: a systematic review with meta-analysis and meta-regression. Eur Eat Disord Rev. 2022;30(4):304\u201327. https:\/\/doi.org\/10.1002\/erv.2906.","journal-title":"Eur Eat Disord Rev"},{"issue":"6","key":"10047_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/obr.12017","volume":"14","author":"K Schag","year":"2013","unstructured":"Schag K, Sch\u00f6nleber J, Teufel M, Zipfel S, Giel KE. Food-related impulsivity in obesity and binge eating disorder--a systematic review. Obes Rev. 2013;14(6):477\u201395. https:\/\/doi.org\/10.1111\/obr.12017.","journal-title":"Obes Rev"},{"issue":"3","key":"10047_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2174\/1874473711104030201","volume":"4","author":"AN Gearhardt","year":"2011","unstructured":"Gearhardt AN, White MA, Potenza MN. Binge eating disorder and food addiction. Curr Drug Abuse Rev. 2011;4(3):201\u20137. https:\/\/doi.org\/10.2174\/1874473711104030201.","journal-title":"Curr Drug Abuse Rev"},{"issue":"9","key":"10047_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.biopsych.2013.01.014","volume":"73","author":"IM Balodis","year":"2013","unstructured":"Balodis IM, Kober H, Worhunsky PD, White MA, Stevens MC, Pearlson GD, et al. Monetary reward processing in obese individuals with and without binge eating disorder. Biol Psychiatry. 2013;73(9):877\u201386. https:\/\/doi.org\/10.1016\/j.biopsych.2013.01.014.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10047_CR13","first-page":"255","volume":"38","author":"YH Yau","year":"2013","unstructured":"Yau YH, Potenza MN. Stress and eating behaviors. Minerva Endocrinol. 2013;38(3):255\u201367.","journal-title":"Minerva Endocrinol"},{"issue":"2","key":"10047_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40519-018-0487-0","volume":"24","author":"K Sainsbury","year":"2019","unstructured":"Sainsbury K, Evans EH, Pedersen S, Marques MM, Teixeira PJ, L\u00e4hteenm\u00e4ki L, et al. Attribution of weight regain to emotional reasons amongst European adults with overweight and obesity who regained weight following a weight loss attempt. Eat Weight Disord. 2019;24(2):351\u201361. https:\/\/doi.org\/10.1007\/s40519-018-0487-0.","journal-title":"Eat Weight Disord"},{"issue":"7","key":"10047_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41366-025-01772-y","volume":"49","author":"S Schrempft","year":"2025","unstructured":"Schrempft S, Jim\u00e9nez-S\u00e1nchez C, Baysson H, Zaballa ME, Lamour J, Stringhini S, et al. Pathways linking BMI trajectories and mental health in an adult population-based cohort: role of emotional eating and body dissatisfaction. Int J Obes (Lond). 2025;49(7):1317\u201326. https:\/\/doi.org\/10.1038\/s41366-025-01772-y.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10047_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","volume":"67","author":"FS Luppino","year":"2010","unstructured":"Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220\u20139. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.2.","journal-title":"Arch Gen Psychiatry"},{"key":"10047_CR17","doi-asserted-by":"publisher","first-page":"880230","DOI":"10.3389\/fendo.2022.880230","volume":"13","author":"Z Wang","year":"2022","unstructured":"Wang Z, Cheng Y, Li Y, Han J, Yuan Z, Li Q, et al. The relationship between obesity and depression is partly dependent on metabolic health status: A nationwide inpatient sample database study. Front Endocrinol (Lausanne). 2022;13:880230. https:\/\/doi.org\/10.3389\/fendo.2022.880230.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10047_CR18","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/ije\/dyy223","volume":"48","author":"J Tyrrell","year":"2019","unstructured":"Tyrrell J, Mulugeta A, Wood AR, Zhou A, Beaumont RN, Tuke MA, et al. Using genetics to understand the causal influence of higher BMI on depression. Int J Epidemiol. 2019;48(3):834\u201348. https:\/\/doi.org\/10.1093\/ije\/dyy223.","journal-title":"Int J Epidemiol"},{"key":"10047_CR19","doi-asserted-by":"publisher","first-page":"1206283","DOI":"10.3389\/fpubh.2023.1206283","volume":"11","author":"GA Rindler","year":"2023","unstructured":"Rindler GA, Gries A, Freidl W. Associations between overweight, obesity, and mental health: a retrospective study among European adults aged 50. Front Public Health. 2023;11:1206283. https:\/\/doi.org\/10.3389\/fpubh.2023.1206283.","journal-title":"Front Public Health"},{"issue":"8","key":"10047_CR20","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","volume":"24","author":"DJ Drucker","year":"2025","unstructured":"Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov. 2025;24(8):631\u201350. https:\/\/doi.org\/10.1038\/s41573-025-01183-8.","journal-title":"Nat Rev Drug Discov"},{"key":"10047_CR21","doi-asserted-by":"publisher","first-page":"100333","DOI":"10.1016\/j.jcte.2024.100333","volume":"35","author":"L Aoun","year":"2024","unstructured":"Aoun L, Almardini S, Saliba F, Haddadin F, Mourad O, Jdaidani J, et al. GLP-1 receptor agonists: a novel pharmacotherapy for binge eating (binge eating disorder and bulimia nervosa)? A systematic review. J Clin Transl Endocrinol. 2024;35:100333. https:\/\/doi.org\/10.1016\/j.jcte.2024.100333.","journal-title":"J Clin Transl Endocrinol"},{"issue":"2","key":"10047_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1176\/appi.ajp.2007.07060951","volume":"165","author":"KT Eddy","year":"2008","unstructured":"Eddy KT, Dorer DJ, Franko DL, Tahilani K, Thompson-Brenner H, Herzog DB. Diagnostic crossover in anorexia nervosa and bulimia nervosa: implications for DSM-V. Am J Psychiatry. 2008;165(2):245\u201350. https:\/\/doi.org\/10.1176\/appi.ajp.2007.07060951.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10047_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/PSY.0b013e31820a1838","volume":"73","author":"G Castellini","year":"2011","unstructured":"Castellini G, Lo Sauro C, Mannucci E, Ravaldi C, Rotella CM, Faravelli C, et al. Diagnostic crossover and outcome predictors in eating disorders according to DSM-IV and DSM-V proposed criteria: a 6-year follow-up study. Psychosom Med. 2011;73(3):270\u20139. https:\/\/doi.org\/10.1097\/PSY.0b013e31820a1838.","journal-title":"Psychosom Med"},{"issue":"3","key":"10047_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","volume":"21","author":"TD M\u00fcller","year":"2022","unstructured":"M\u00fcller TD, Bl\u00fcher M, Tsch\u00f6p MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022;21(3):201\u201323. https:\/\/doi.org\/10.1038\/s41573-021-00337-8.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10047_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pr.117.014803","volume":"70","author":"TD M\u00fcller","year":"2018","unstructured":"M\u00fcller TD, Clemmensen C, Finan B, DiMarchi RD, Tsch\u00f6p MH. Anti-obesity therapy: from rainbow pills to polyagonists. Pharmacol Rev. 2018;70(4):712\u201346. https:\/\/doi.org\/10.1124\/pr.117.014803.","journal-title":"Pharmacol Rev"},{"key":"10047_CR26","doi-asserted-by":"publisher","first-page":"103020","DOI":"10.1016\/j.eclinm.2024.103020","volume":"79","author":"L Liu","year":"2025","unstructured":"Liu L, Li Z, Ye W, Peng P, Wang Y, Wan L, et al. Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine. 2025;79:103020. https:\/\/doi.org\/10.1016\/j.eclinm.2024.103020.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10047_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4093\/dmj.2012.36.1.13","volume":"36","author":"JG Kang","year":"2012","unstructured":"Kang JG, Park CY. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J. 2012;36(1):13\u201325. https:\/\/doi.org\/10.4093\/dmj.2012.36.1.13.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"10047_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/dc24-1678","volume":"48","author":"HJ Wong","year":"2025","unstructured":"Wong HJ, Sim B, Teo YH, Teo YN, Chan MY, Yeo LLL, et al. Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials. Diabetes Care. 2025;48(2):292\u2013300. https:\/\/doi.org\/10.2337\/dc24-1678.","journal-title":"Diabetes Care"},{"issue":"2","key":"10047_CR29","doi-asserted-by":"publisher","first-page":"e0314787","DOI":"10.1371\/journal.pone.0314787","volume":"20","author":"S Yang","year":"2025","unstructured":"Yang S, Xin S, Ju R, Zang P. Pharmacological interventions for addressing pediatric and adolescent obesity: a systematic review and network meta-analysis. PLoS ONE. 2025;20(2):e0314787. https:\/\/doi.org\/10.1371\/journal.pone.0314787.","journal-title":"PLoS ONE"},{"issue":"10434","key":"10047_CR30","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/s0140-6736(24)00351-9","volume":"403","author":"Q Shi","year":"2024","unstructured":"Shi Q, Wang Y, Hao Q, Vandvik PO, Guyatt G, Li J, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2024;403(10434):e21\u201331. https:\/\/doi.org\/10.1016\/s0140-6736(24)00351-9.","journal-title":"Lancet"},{"issue":"6","key":"10047_CR31","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.amjmed.2025.01.021","volume":"138","author":"A Moiz","year":"2025","unstructured":"Moiz A, Filion KB, Tsoukas MA, Yu OHY, Peters TM, Eisenberg MJ. Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation. Am J Med. 2025;138(6):934\u201340. https:\/\/doi.org\/10.1016\/j.amjmed.2025.01.021.","journal-title":"Am J Med"},{"issue":"1","key":"10047_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s40519-025-01720-9","volume":"30","author":"H Radkhah","year":"2025","unstructured":"Radkhah H, Rahimipour Anaraki S, Parhizkar Roudsari P, Arabzadeh Bahri R, Zooravar D, Asgarian S, et al. The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis. Eat Weight Disord. 2025;30(1):10. https:\/\/doi.org\/10.1007\/s40519-025-01720-9.","journal-title":"Eat Weight Disord"},{"issue":"7","key":"10047_CR33","doi-asserted-by":"publisher","first-page":"e70661","DOI":"10.1002\/brb3.70661","volume":"15","author":"S Meshkat","year":"2025","unstructured":"Meshkat S, Di Luciano C, Swiderski A, Li G, Aguilar RJ, Dunkley BT, et al. Efficacy and safety of Glucagon-Like Peptide-1 agonists for psychiatric symptoms: a systematic review. Brain Behav. 2025;15(7):e70661. https:\/\/doi.org\/10.1002\/brb3.70661.","journal-title":"Brain Behav"},{"issue":"6","key":"10047_CR34","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1038\/s41440-025-02152-9","volume":"48","author":"Y Akasaki","year":"2025","unstructured":"Akasaki Y, Suematsu Y, Azushima K, Shiga Y, Sakima A, Satoh M, et al. Impact of patient care teams on blood pressure control in patients with hypertension: a systematic review and meta-analysis. Hypertens Res. 2025;48(6):1827\u201338. https:\/\/doi.org\/10.1038\/s41440-025-02152-9.","journal-title":"Hypertens Res"},{"issue":"11","key":"10047_CR35","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/jama.2018.13022","volume":"320","author":"SJ Curry","year":"2018","unstructured":"Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(11):1163\u201371. https:\/\/doi.org\/10.1001\/jama.2018.13022.","journal-title":"JAMA"},{"issue":"25 Suppl 2","key":"10047_CR36","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102\u201338. https:\/\/doi.org\/10.1161\/01.cir.0000437739.71477.ee.","journal-title":"Circulation"},{"issue":"2","key":"10047_CR37","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000350627","volume":"6","author":"G Fr\u00fchbeck","year":"2013","unstructured":"Fr\u00fchbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM. Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6(2):117\u201320. https:\/\/doi.org\/10.1159\/000350627.","journal-title":"Obes Facts"},{"key":"10047_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2147\/DMSO.S387116","volume":"16","author":"M Aldawsari","year":"2023","unstructured":"Aldawsari M, Almadani FA, Almuhammadi N, Algabsani S, Alamro Y, Aldhwayan M. The efficacy of GLP-1 analogues on appetite parameters, gastric emptying, food preference and taste among adults with obesity: systematic review of randomized controlled trials. Diabetes, Metab Syndr Obes. 2023;16:575\u201395.","journal-title":"Diabetes, Metab Syndr Obes"},{"issue":"12","key":"10047_CR39","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.2337\/db14-0849","volume":"63","author":"L van Bloemendaal","year":"2014","unstructured":"van Bloemendaal L, Ij RG, Ten Kulve JS, Barkhof F, Konrad RJ, Drent ML, et al. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 2014;63(12):4186\u201396. https:\/\/doi.org\/10.2337\/db14-0849.","journal-title":"Diabetes"},{"issue":"10","key":"10047_CR40","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1038\/s41591-025-03978-z","volume":"31","author":"B McGowan","year":"2025","unstructured":"McGowan B, Ciudin A, Baker JL, Busetto L, Dicker D, Fr\u00fchbeck G, et al. A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults. Nat Med. 2025;31(10):3317\u201329. https:\/\/doi.org\/10.1038\/s41591-025-03978-z.","journal-title":"Nat Med"},{"issue":"1","key":"10047_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","volume":"32","author":"X Chen","year":"2024","unstructured":"Chen X, Zhao P, Wang W, Guo L, Pan Q. The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2024;32(1):117\u201327. https:\/\/doi.org\/10.1016\/j.jagp.2023.08.010.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"10047_CR42","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1111\/dom.15538","volume":"26","author":"GA Silverii","year":"2024","unstructured":"Silverii GA, Marinelli C, Mannucci E, Rotella F. Glucagon-like peptide-1 receptor agonists and mental health: A meta-analysis of randomized controlled trials. Diabetes, Obes Metab. 2024;26(6):2505\u20138.","journal-title":"Diabetes, Obes Metab"},{"issue":"1","key":"10047_CR43","doi-asserted-by":"publisher","first-page":"24433","DOI":"10.1038\/s41598-024-75965-2","volume":"14","author":"E Kornelius","year":"2024","unstructured":"Kornelius E, Huang JY, Lo SC, Huang CN, Yang YS. The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy. Sci Rep. 2024;14(1):24433. https:\/\/doi.org\/10.1038\/s41598-024-75965-2.","journal-title":"Sci Rep"},{"issue":"11","key":"10047_CR44","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s00125-024-06243-z","volume":"67","author":"I Hurtado","year":"2024","unstructured":"Hurtado I, Robles C, Peir\u00f3 S, Garc\u00eda-Sempere A, Sanf\u00e9lix-Gimeno G. Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study. Diabetologia. 2024;67(11):2471\u201380. https:\/\/doi.org\/10.1007\/s00125-024-06243-z.","journal-title":"Diabetologia"},{"key":"10047_CR45","unstructured":"(EMA) EMA. Association between exposure to GLP-1 receptor agonists and risk of suicide-related and self-injury-related events. 2024. Report No.: EUPAS1000000052."},{"key":"10047_CR46","unstructured":"Administration USFaD. FDA Drug Safety Communication: Update on FDA\u2019s ongoing evaluation of reports of suicidal thoughts or actions in patients taking certain GLP-1 receptor agonists. 2024 11 January 2024."},{"issue":"11","key":"10047_CR47","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamainternmed.2024.4369","volume":"184","author":"P Ueda","year":"2024","unstructured":"Ueda P, S\u00f6derling J, Wintzell V, Svanstr\u00f6m H, Pazzagli L, Eliasson B, et al. GLP-1 receptor agonist use and risk of suicide death. JAMA Intern Med. 2024;184(11):1301\u201312. https:\/\/doi.org\/10.1001\/jamainternmed.2024.4369.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10047_CR48","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamapsychiatry.2025.0091","volume":"82","author":"P Ebrahimi","year":"2025","unstructured":"Ebrahimi P, Batlle JC, Ayati A, Maqsood MH, Long C, Tarabanis C, et al. Suicide and self-harm events with GLP-1 receptor agonists in adults with diabetes or obesity: a systematic review and meta-analysis. JAMA Psychiat. 2025;82(9):888\u201395. https:\/\/doi.org\/10.1001\/jamapsychiatry.2025.0091.","journal-title":"JAMA Psychiat"},{"issue":"9","key":"10047_CR49","doi-asserted-by":"publisher","first-page":"e70151","DOI":"10.1111\/1753-0407.70151","volume":"17","author":"J Chen","year":"2025","unstructured":"Chen J, Zhang Q, Wu Q, Zhang X, Xiang Z, Zhu S, et al. Impact of GLP-1 receptor agonists on suicide behavior: a meta-analysis based on randomized controlled trials. J Diabetes. 2025;17(9):e70151. https:\/\/doi.org\/10.1111\/1753-0407.70151.","journal-title":"J Diabetes"},{"issue":"1","key":"10047_CR50","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41591-023-02672-2","volume":"30","author":"W Wang","year":"2024","unstructured":"Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nat Med. 2024;30(1):168\u201376. https:\/\/doi.org\/10.1038\/s41591-023-02672-2.","journal-title":"Nat Med"},{"key":"10047_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04228-1","author":"LM Romariz","year":"2025","unstructured":"Romariz LM, de Melo AAC, Finnegan E, Mesquita Y, Janovsky C. GLP-1 receptor agonists for the treatment of obesity in children and adolescents: a meta-analysis of randomized controlled trials. Pediatr Res. 2025. https:\/\/doi.org\/10.1038\/s41390-025-04228-1.","journal-title":"Pediatr Res"},{"issue":"6","key":"10047_CR52","doi-asserted-by":"publisher","first-page":"e70262","DOI":"10.1111\/cts.70262","volume":"18","author":"M Bartkoski","year":"2025","unstructured":"Bartkoski M, Poweleit EA, Stancil SL. GLP-1 agonists for pediatric psychopharmacology: opportunities and cautions. Clin Transl Sci. 2025;18(6):e70262. https:\/\/doi.org\/10.1111\/cts.70262.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"10047_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/dom.12119","volume":"16","author":"S Madsbad","year":"2014","unstructured":"Madsbad S. The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications. Diabetes Obes Metab. 2014;16(1):9\u201321. https:\/\/doi.org\/10.1111\/dom.12119.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10047_CR54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.physbeh.2008.04.013","volume":"94","author":"A Geliebter","year":"2008","unstructured":"Geliebter A, Hashim SA, Gluck ME. Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED). Physiol Behav. 2008;94(5):696\u20139. https:\/\/doi.org\/10.1016\/j.physbeh.2008.04.013.","journal-title":"Physiol Behav"},{"key":"10047_CR55","doi-asserted-by":"publisher","unstructured":"Balantekin KN, Kretz MJ, Mietlicki-Baase EG. The emerging role of glucagon-like peptide 1 in binge eating. J Endocrinol. 2024;262(1). https:\/\/doi.org\/10.1530\/joe-23-0405.","DOI":"10.1530\/joe-23-0405"},{"issue":"4","key":"10047_CR56","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3945\/ajcn.111.014837","volume":"94","author":"S Naess\u00e9n","year":"2011","unstructured":"Naess\u00e9n S, Carlstr\u00f6m K, Holst JJ, Hellstr\u00f6m PM, Hirschberg AL. Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal. Am J Clin Nutr. 2011;94(4):967\u201372. https:\/\/doi.org\/10.3945\/ajcn.111.014837.","journal-title":"Am J Clin Nutr"},{"key":"10047_CR57","doi-asserted-by":"publisher","unstructured":"Perez-Cheron M. Remission of Bulimia Nervosa Observed During Administration of Liraglutide and Metformin: A Case Report. AACE Clinical Case Reports. 2018;4(3):199\u2013202. https:\/\/doi.org\/10.4158\/EP161667.CR","DOI":"10.4158\/EP161667.CR"},{"issue":"10","key":"10047_CR58","doi-asserted-by":"publisher","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","volume":"310","author":"SE Kanoski","year":"2016","unstructured":"Kanoski SE, Hayes MR, Skibicka KP. GLP-1 and weight loss: unraveling the diverse neural circuitry. Am J Physiol Regul Integr Comp Physiol. 2016;310(10):R885\u201395. https:\/\/doi.org\/10.1152\/ajpregu.00520.2015.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10047_CR59","doi-asserted-by":"publisher","first-page":"112565","DOI":"10.1016\/j.physbeh.2019.112565","volume":"208","author":"PK Keel","year":"2019","unstructured":"Keel PK, Bodell LP, Forney KJ, Appelbaum J, Williams D. Examining weight suppression as a transdiagnostic factor influencing illness trajectory in bulimic eating disorders. Physiol Behav. 2019;208:112565. https:\/\/doi.org\/10.1016\/j.physbeh.2019.112565.","journal-title":"Physiol Behav"},{"key":"10047_CR60","doi-asserted-by":"publisher","first-page":"114622","DOI":"10.1016\/j.physbeh.2024.114622","volume":"283","author":"S Badulescu","year":"2024","unstructured":"Badulescu S, Tabassum A, Le GH, Wong S, Phan L, Gill H, et al. Glucagon-like peptide 1 agonist and effects on reward behaviour: a systematic review. Physiol Behav. 2024;283:114622. https:\/\/doi.org\/10.1016\/j.physbeh.2024.114622.","journal-title":"Physiol Behav"},{"issue":"10","key":"10047_CR61","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/oby.21200","volume":"23","author":"L van Bloemendaal","year":"2015","unstructured":"van Bloemendaal L, Veltman DJ, ten Kulve JS, Drent ML, Barkhof F, Diamant M, et al. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation. Obesity Silver Spring. 2015;23(10):2075\u201382. https:\/\/doi.org\/10.1002\/oby.21200.","journal-title":"Obesity Silver Spring"},{"key":"10047_CR62","doi-asserted-by":"publisher","first-page":"105667","DOI":"10.1016\/j.psyneuen.2022.105667","volume":"137","author":"CC van Ruiten","year":"2022","unstructured":"van Ruiten CC, Ten Kulve JS, van Bloemendaal L, Nieuwdorp M, Veltman DJ, Ij RG. Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trial. Psychoneuroendocrinology. 2022;137:105667. https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105667.","journal-title":"Psychoneuroendocrinology"},{"key":"10047_CR63","doi-asserted-by":"publisher","first-page":"113967","DOI":"10.1016\/j.physbeh.2022.113967","volume":"257","author":"J Nicolau","year":"2022","unstructured":"Nicolau J, Pujol A, Tof\u00e9 S, Bonet A, Gil A. Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity. Physiol Behav. 2022;257:113967. https:\/\/doi.org\/10.1016\/j.physbeh.2022.113967.","journal-title":"Physiol Behav"},{"issue":"9","key":"10047_CR64","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/dom.12932","volume":"19","author":"J Blundell","year":"2017","unstructured":"Blundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242\u201351. https:\/\/doi.org\/10.1111\/dom.12932.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10047_CR65","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/dom.14280","volume":"23","author":"M Friedrichsen","year":"2021","unstructured":"Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23(3):754\u201362. https:\/\/doi.org\/10.1111\/dom.14280.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10047_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1056\/NEJMoa2416394","volume":"393","author":"LJ Aronne","year":"2025","unstructured":"Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, et al. Tirzepatide as compared with semaglutide for the treatment of obesity. N Engl J Med. 2025;393(1):26\u201336. https:\/\/doi.org\/10.1056\/NEJMoa2416394.","journal-title":"N Engl J Med"},{"issue":"9","key":"10047_CR67","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1038\/s41591-025-03774-9","volume":"31","author":"CK Martin","year":"2025","unstructured":"Martin CK, Carmichael OT, Carnell S, Considine RV, Kareken DA, Dydak U, et al. Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial. Nat Med. 2025;31(9):3141\u201350. https:\/\/doi.org\/10.1038\/s41591-025-03774-9.","journal-title":"Nat Med"},{"issue":"2","key":"10047_CR68","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2337\/dc15-0772","volume":"39","author":"JS Ten Kulve","year":"2016","unstructured":"Ten Kulve JS, Veltman DJ, van Bloemendaal L, Barkhof F, Drent ML, Diamant M, et al. Liraglutide reduces CNS activation in response to visual food cues only after short-term treatment in patients with type 2 diabetes. Diabetes Care. 2016;39(2):214\u201321. https:\/\/doi.org\/10.2337\/dc15-0772.","journal-title":"Diabetes Care"},{"issue":"8","key":"10047_CR69","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1038\/s42255-023-00859-y","volume":"5","author":"R Hanssen","year":"2023","unstructured":"Hanssen R, Rigoux L, Kuzmanovic B, Iglesias S, Kretschmer AC, Schlamann M, et al. Liraglutide restores impaired associative learning in individuals with obesity. Nat Metab. 2023;5(8):1352\u201363. https:\/\/doi.org\/10.1038\/s42255-023-00859-y.","journal-title":"Nat Metab"},{"issue":"1","key":"10047_CR70","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/00315125221133868","volume":"130","author":"ALL Souza","year":"2023","unstructured":"Souza ALL, de Souza PM, Mota BEF, Xavier CLF, Santiago FG, Oliveira JS, et al. Ghost fat: altered female body perception after bariatric surgery. Percept Mot Skills. 2023;130(1):301\u201316. https:\/\/doi.org\/10.1177\/00315125221133868.","journal-title":"Percept Mot Skills"},{"issue":"10","key":"10047_CR71","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1177\/1359105313511838","volume":"20","author":"J Gilmartin","year":"2015","unstructured":"Gilmartin J, Long A, Soldin M. Identity transformation and a changed lifestyle following dramatic weight loss and body-contouring surgery: an exploratory study. J Health Psychol. 2015;20(10):1318\u201327. https:\/\/doi.org\/10.1177\/1359105313511838.","journal-title":"J Health Psychol"},{"key":"10047_CR72","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3389\/fpsyt.2019.00852","volume":"10","author":"K Ziser","year":"2019","unstructured":"Ziser K, Finklenburg C, Behrens SC, Giel KE, Becker S, Skoda EM, et al. Perceived stress mediates the relationship of body image and depressive symptoms in individuals with obesity. Front Psychiatry. 2019;10:852. https:\/\/doi.org\/10.3389\/fpsyt.2019.00852.","journal-title":"Front Psychiatry"},{"issue":"4","key":"10047_CR73","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1007\/s11695-020-05057-3","volume":"31","author":"SC Behrens","year":"2021","unstructured":"Behrens SC, Lenhard K, Junne F, Ziser K, Lange J, Zipfel S, et al. Effects of bariatric surgery on depression: role of body image. Obes Surg. 2021;31(4):1864\u20138. https:\/\/doi.org\/10.1007\/s11695-020-05057-3.","journal-title":"Obes Surg"},{"issue":"11","key":"10047_CR74","doi-asserted-by":"publisher","first-page":"e0166826","DOI":"10.1371\/journal.pone.0166826","volume":"11","author":"SC M\u00f6lbert","year":"2016","unstructured":"M\u00f6lbert SC, Sauer H, Dammann D, Zipfel S, Teufel M, Junne F, et al. Multimodal body representation of obese children and adolescents before and after weight-loss treatment in comparison to normal-weight children. PLoS ONE. 2016;11(11):e0166826. https:\/\/doi.org\/10.1371\/journal.pone.0166826.","journal-title":"PLoS ONE"},{"issue":"1","key":"10047_CR75","doi-asserted-by":"publisher","first-page":"22876","DOI":"10.3402\/qhw.v9.22876","volume":"9","author":"C Warholm","year":"2014","unstructured":"Warholm C, \u00d8ien AM, R\u00e5heim M. The ambivalence of losing weight after bariatric surgery. Int J Qual Stud Health Well Being. 2014;9(1):22876.","journal-title":"Int J Qual Stud Health Well Being"},{"issue":"9-10","key":"10047_CR76","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/jocn.12031","volume":"22","author":"J Gilmartin","year":"2013","unstructured":"Gilmartin J. Body image concerns amongst massive weight loss patients. J Clin Nurs. 2013;22(9\u201310):1299\u2013309.","journal-title":"J Clin Nurs"},{"issue":"7","key":"10047_CR77","doi-asserted-by":"publisher","first-page":"e093357","DOI":"10.1136\/bmjopen-2024-093357","volume":"15","author":"R Dahl-Larsen","year":"2025","unstructured":"Dahl-Larsen R, Jakobsen PR, S\u00f8ndergaard J, Henriksen JE, Assing Hvidt E. Patient experiences with group consultations when treated with semaglutide for obesity: a qualitative case study in a Danish general practice. BMJ Open. 2025;15(7):e093357. https:\/\/doi.org\/10.1136\/bmjopen-2024-093357.","journal-title":"BMJ Open"},{"issue":"1","key":"10047_CR78","doi-asserted-by":"publisher","first-page":"e70069","DOI":"10.1111\/bcpt.70069","volume":"137","author":"T Graab\u00e6k","year":"2025","unstructured":"Graab\u00e6k T, Nguyen NT, S\u00f8rensen MS, Lundby C. \u201cThis is my decision\u201d: a qualitative study of individuals\u2019 perspectives on use of semaglutide for weight loss. Basic Clin Pharmacol Toxicol. 2025;137(1):e70069. https:\/\/doi.org\/10.1111\/bcpt.70069.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"11","key":"10047_CR79","doi-asserted-by":"publisher","first-page":"e13608","DOI":"10.1111\/obr.13608","volume":"24","author":"W MacAskill","year":"2023","unstructured":"MacAskill W, Gillanders T, Wylie N, Pinidiyapathirage J. Finding what works-patients\u2019 long-term experiences of weight maintenance post bariatric surgery: a systematic review and thematic synthesis of qualitative studies. Obes Rev. 2023;24(11):e13608. https:\/\/doi.org\/10.1111\/obr.13608.","journal-title":"Obes Rev"},{"key":"10047_CR80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40608-018-0215-3","volume":"5","author":"DH Griauzde","year":"2018","unstructured":"Griauzde DH, Ibrahim AM, Fisher N, Stricklen A, Ross R, Ghaferi AA. Understanding the psychosocial impact of weight loss following bariatric surgery: a qualitative study. BMC Obes. 2018;5:38. https:\/\/doi.org\/10.1186\/s40608-018-0215-3.","journal-title":"BMC Obes"},{"key":"10047_CR81","doi-asserted-by":"publisher","unstructured":"Van Zyl N, Lusher J, Meyrick J. A qualitative exploration of postoperative bariatric patients' psychosocial support for long-term weight loss and psychological wellbeing. Behav Sci (Basel). 2024;14(2). https:\/\/doi.org\/10.3390\/bs14020122.","DOI":"10.3390\/bs14020122"},{"issue":"2","key":"10047_CR82","doi-asserted-by":"publisher","first-page":"e009389","DOI":"10.1136\/bmjopen-2015-009389","volume":"6","author":"CV Homer","year":"2016","unstructured":"Homer CV, Tod AM, Thompson AR, Allmark P, Goyder E. Expectations and patients\u2019 experiences of obesity prior to bariatric surgery: a qualitative study. BMJ Open. 2016;6(2):e009389. https:\/\/doi.org\/10.1136\/bmjopen-2015-009389.","journal-title":"BMJ Open"},{"issue":"6","key":"10047_CR83","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40271-023-00644-9","volume":"16","author":"R Watkins","year":"2023","unstructured":"Watkins R, Swancutt D, Alexander M, Moghadam S, Perry S, Dean S, et al. A qualitative exploration of patient and staff experiences of the receipt and delivery of specialist weight management services in the UK. Patient. 2023;16(6):625\u201340. https:\/\/doi.org\/10.1007\/s40271-023-00644-9.","journal-title":"Patient"},{"issue":"8","key":"10047_CR84","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/s41366-025-01789-3","volume":"49","author":"HC Craig","year":"2025","unstructured":"Craig HC, Alsaeed D, Al Ozairi E, Norris S, Holian J, Kennedy C, et al. Factors influencing patients to choose one obesity treatment over another: a qualitative study. Int J Obes Lond. 2025;49(8):1554\u201365. https:\/\/doi.org\/10.1038\/s41366-025-01789-3.","journal-title":"Int J Obes Lond"},{"issue":"S2","key":"10047_CR85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/dom.16255","volume":"27","author":"SW Flint","year":"2025","unstructured":"Flint SW, V\u00e1zquez-Vel\u00e1zquez V, Le Brocq S, Brown A. The real-life experiences of people living with overweight and obesity: a psychosocial perspective. Diabetes Obes Metab. 2025;27(S2):35\u201347. https:\/\/doi.org\/10.1111\/dom.16255.","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10047_CR86","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41366-024-01516-4","volume":"48","author":"SM Post","year":"2024","unstructured":"Post SM, Persky S. The effect of GLP-1 receptor agonist use on negative evaluations of women with higher and lower body weight. Int J Obes (Lond). 2024;48(7):1019\u201326. https:\/\/doi.org\/10.1038\/s41366-024-01516-4.","journal-title":"Int J Obes (Lond)"},{"key":"10047_CR87","doi-asserted-by":"publisher","first-page":"101398","DOI":"10.1016\/j.lanepe.2025.101398","volume":"56","author":"RB Hasselbalch","year":"2025","unstructured":"Hasselbalch RB, Andrea MK, Nols\u00f8e CV, Hindborg M, Yazdanfard PDW, S\u00f8rensen KK, et al. Association between socioeconomic factors and semaglutide use for weight loss: a population-based cross-sectional study in Denmark. Lancet Reg Health-Europe. 2025;56:101398.","journal-title":"Lancet Reg Health-Europe."},{"issue":"1","key":"10047_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41591-023-02669-x","volume":"30","author":"SW Waldrop","year":"2024","unstructured":"Waldrop SW, Johnson VR, Stanford FC. Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity. Nat Med. 2024;30(1):22\u20135.","journal-title":"Nat Med"},{"issue":"1","key":"10047_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s13679-025-00611-5","volume":"14","author":"BL Heitmann","year":"2025","unstructured":"Heitmann BL. The impact of novel medications for obesity on weight stigma and societal attitudes: a narrative review. Curr Obes Rep. 2025;14(1):18.","journal-title":"Curr Obes Rep"},{"issue":"1","key":"10047_CR90","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jada.2010.10.008","volume":"111","author":"LE Burke","year":"2011","unstructured":"Burke LE, Wang J, Sevick MA. Self-monitoring in weight loss: a systematic review of the literature. J Am Diet Assoc. 2011;111(1):92\u2013102. https:\/\/doi.org\/10.1016\/j.jada.2010.10.008.","journal-title":"J Am Diet Assoc"},{"key":"10047_CR91","doi-asserted-by":"publisher","unstructured":"Cavero-Redondo I, Martinez-Vizcaino V, Fernandez-Rodriguez R, Saz-Lara A, Pascual-Morena C, \u00c1lvarez-Bueno C. Effect of behavioral weight management interventions using lifestyle mHealth self-monitoring on weight loss: a systematic review and meta-analysis. Nutrients. 2020;12(7). https:\/\/doi.org\/10.3390\/nu12071977.","DOI":"10.3390\/nu12071977"},{"issue":"3","key":"10047_CR92","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/oby.23088","volume":"29","author":"ML Patel","year":"2021","unstructured":"Patel ML, Wakayama LN, Bennett GG. Self-monitoring via digital health in weight loss interventions: a systematic review among adults with overweight or obesity. Obesity (Silver Spring). 2021;29(3):478\u201399. https:\/\/doi.org\/10.1002\/oby.23088.","journal-title":"Obesity (Silver Spring)"},{"issue":"1 Suppl","key":"10047_CR93","doi-asserted-by":"publisher","first-page":"222s","DOI":"10.1093\/ajcn\/82.1.222S","volume":"82","author":"RR Wing","year":"2005","unstructured":"Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005;82(1 Suppl):222s-s225. https:\/\/doi.org\/10.1093\/ajcn\/82.1.222S.","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10047_CR94","doi-asserted-by":"publisher","first-page":"e18080","DOI":"10.7759\/cureus.18080","volume":"13","author":"IV Olateju","year":"2021","unstructured":"Olateju IV, Ogwu D, Owolabi MO, Azode U, Osula F, Okeke R, et al. Role of behavioral interventions in the management of obesity. Cureus. 2021;13(9):e18080. https:\/\/doi.org\/10.7759\/cureus.18080.","journal-title":"Cureus"},{"issue":"1","key":"10047_CR95","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1037\/0022-006x.67.1.132","volume":"67","author":"RR Wing","year":"1992","unstructured":"Wing RR, Jeffery RW. Benefits of recruiting participants with friends and increasing social support for weight loss and maintenance. J Consult Clin Psychol. 1992;67(1):132\u20138. https:\/\/doi.org\/10.1037\/0022-006x.67.1.132.","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"10047_CR96","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41366-024-01468-9","volume":"48","author":"MT Jensen","year":"2024","unstructured":"Jensen MT, Nielsen SS, Jessen-Winge C, Madsen CMT, Thilsing T, Larrabee S\u00f8nderlund A, et al. The effectiveness of social-support-based weight-loss interventions-a systematic review and meta-analysis. Int J Obes (Lond). 2024;48(5):599\u2013611. https:\/\/doi.org\/10.1038\/s41366-024-01468-9.","journal-title":"Int J Obes (Lond)"},{"key":"10047_CR97","doi-asserted-by":"publisher","first-page":"e085304","DOI":"10.1136\/bmj-2025-085304","volume":"392","author":"S West","year":"2026","unstructured":"West S, Scragg J, Aveyard P, Oke JL, Willis L, Haffner SJP, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ. 2026;392:e085304. https:\/\/doi.org\/10.1136\/bmj-2025-085304.","journal-title":"BMJ"},{"issue":"3","key":"10047_CR98","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13679-023-00515-2","volume":"12","author":"SKE Kupila","year":"2023","unstructured":"Kupila SKE, Joki A, Suojanen LU, Pietil\u00e4inen KH. The effectiveness of eHealth interventions for weight loss and weight loss maintenance in adults with overweight or obesity: a systematic review of systematic reviews. Curr Obes Rep. 2023;12(3):371\u201394. https:\/\/doi.org\/10.1007\/s13679-023-00515-2.","journal-title":"Curr Obes Rep"},{"issue":"6","key":"10047_CR99","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/oby.24027","volume":"32","author":"KD Hall","year":"2024","unstructured":"Hall KD. Physiology of the weight-loss plateau in response to diet restriction, GLP-1 receptor agonism, and bariatric surgery. Obesity (Silver Spring). 2024;32(6):1163\u20138. https:\/\/doi.org\/10.1002\/oby.24027.","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"10047_CR100","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10047_CR101","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0306-4603(82)90024-7","volume":"7","author":"J Gormally","year":"1982","unstructured":"Gormally J, Black S, Daston S, Rardin D. The assessment of binge eating severity among obese persons. Addict Behav. 1982;7(1):47\u201355. https:\/\/doi.org\/10.1016\/0306-4603(82)90024-7.","journal-title":"Addict Behav"},{"issue":"23","key":"10047_CR102","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.2023.9297","volume":"329","author":"Force UPST","year":"2023","unstructured":"Force UPST. Screening for depression and suicide risk in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023;329(23):2057\u201367. https:\/\/doi.org\/10.1001\/jama.2023.9297.","journal-title":"JAMA"},{"issue":"2","key":"10047_CR103","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/cob.12180","volume":"7","author":"E Burgess","year":"2017","unstructured":"Burgess E, Hassm\u00e9n P, Welvaert M, Pumpa KL. Behavioural treatment strategies improve adherence to lifestyle intervention programmes in adults with obesity: a systematic review and meta-analysis. Clin Obes. 2017;7(2):105\u201314. https:\/\/doi.org\/10.1111\/cob.12180.","journal-title":"Clin Obes"},{"issue":"1","key":"10047_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000526945","volume":"16","author":"T Lau","year":"2023","unstructured":"Lau T, Cook J, Archid R, Stengel A, Zipfel S, Mack I. Effects of lifestyle and educational bridging programs before bariatric surgery on postoperative weight loss: a systematic review and meta-analysis. Obes Facts. 2023;16(1):1\u201310. https:\/\/doi.org\/10.1159\/000526945.","journal-title":"Obes Facts"},{"issue":"19","key":"10047_CR105","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.12998\/wjcc.v11.i19.4504","volume":"11","author":"M Gulinac","year":"2023","unstructured":"Gulinac M, Miteva DG, Peshevska-Sekulovska M, Novakov IP, Antovic S, Peruhova M, et al. Long-term effectiveness, outcomes and complications of bariatric surgery. World J Clin Cases. 2023;11(19):4504.","journal-title":"World J Clin Cases"},{"issue":"6","key":"10047_CR106","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.soard.2015.05.018","volume":"11","author":"B Wild","year":"2015","unstructured":"Wild B, H\u00fcnnemeyer K, Sauer H, Hain B, Mack I, Schellberg D, et al. A 1-year videoconferencing-based psychoeducational group intervention following bariatric surgery: results of a randomized controlled study. Surg Obes Relat Dis. 2015;11(6):1349\u201360. https:\/\/doi.org\/10.1016\/j.soard.2015.05.018.","journal-title":"Surg Obes Relat Dis"},{"issue":"4","key":"10047_CR107","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1016\/j.orcp.2013.09.003","volume":"8","author":"CL Wimmelmann","year":"2014","unstructured":"Wimmelmann CL, Dela F, Mortensen EL. Psychological predictors of weight loss after bariatric surgery: a review of the recent research. Obes Res Clin Pract. 2014;8(4):e299-313. https:\/\/doi.org\/10.1016\/j.orcp.2013.09.003.","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"10047_CR108","doi-asserted-by":"publisher","first-page":"e12998","DOI":"10.1111\/obr.12998","volume":"21","author":"D Spirou","year":"2020","unstructured":"Spirou D, Raman J, Smith E. Psychological outcomes following surgical and endoscopic bariatric procedures: a systematic review. Obes Rev. 2020;21(6):e12998. https:\/\/doi.org\/10.1111\/obr.12998.","journal-title":"Obes Rev"},{"issue":"9","key":"10047_CR109","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.soard.2017.03.034","volume":"13","author":"B Wild","year":"2017","unstructured":"Wild B, H\u00fcnnemeyer K, Sauer H, Schellberg D, M\u00fcller-Stich BP, K\u00f6nigsrainer A, et al. Sustained effects of a psychoeducational group intervention following bariatric surgery: follow-up of the randomized controlled BaSE study. Surg Obes Relat Dis. 2017;13(9):1612\u20138. https:\/\/doi.org\/10.1016\/j.soard.2017.03.034.","journal-title":"Surg Obes Relat Dis"},{"issue":"12","key":"10047_CR110","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s11695-016-2219-8","volume":"26","author":"I Mack","year":"2016","unstructured":"Mack I, \u00d6lschl\u00e4ger S, Sauer H, von Feilitzsch M, Weimer K, Junne F, et al. Does laparoscopic sleeve gastrectomy improve depression, stress and eating behaviour? A 4-year follow-up study. Obes Surg. 2016;26(12):2967\u201373. https:\/\/doi.org\/10.1007\/s11695-016-2219-8.","journal-title":"Obes Surg"},{"issue":"1","key":"10047_CR111","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.soard.2009.08.011","volume":"6","author":"M de Zwaan","year":"2010","unstructured":"de Zwaan M, Hilbert A, Swan-Kremeier L, Simonich H, Lancaster K, Howell LM, et al. Comprehensive interview assessment of eating behavior 18-35 months after gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2010;6(1):79\u201385. https:\/\/doi.org\/10.1016\/j.soard.2009.08.011.","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"10047_CR112","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1001\/jamasurg.2016.0395","volume":"151","author":"JE Mitchell","year":"2016","unstructured":"Mitchell JE, Christian NJ, Flum DR, Pomp A, Pories WJ, Wolfe BM, et al. Postoperative behavioral variables and weight change 3 years after bariatric surgery. JAMA Surg. 2016;151(8):752\u20137. https:\/\/doi.org\/10.1001\/jamasurg.2016.0395.","journal-title":"JAMA Surg"},{"issue":"5","key":"10047_CR113","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jamasurg.2017.5025","volume":"153","author":"AP Courcoulas","year":"2018","unstructured":"Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-year weight trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study. JAMA Surg. 2018;153(5):427\u201334. https:\/\/doi.org\/10.1001\/jamasurg.2017.5025.","journal-title":"JAMA Surg"},{"issue":"7","key":"10047_CR114","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s11695-023-06586-3","volume":"33","author":"RJ Franken","year":"2023","unstructured":"Franken RJ, de Laar AWV. Evidence-based classification for post-bariatric weight regain from a benchmark registry cohort of 18,403 patients and comparison with current criteria. Obes Surg. 2023;33(7):2040\u20138. https:\/\/doi.org\/10.1007\/s11695-023-06586-3.","journal-title":"Obes Surg"},{"issue":"3","key":"10047_CR115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11892-023-01498-z","volume":"23","author":"SF Noria","year":"2023","unstructured":"Noria SF, Shelby RD, Atkins KD, Nguyen NT, Gadde KM. Weight regain after bariatric surgery: scope of the problem, causes, prevention, and treatment. Curr Diab Rep. 2023;23(3):31\u201342. https:\/\/doi.org\/10.1007\/s11892-023-01498-z.","journal-title":"Curr Diab Rep"},{"key":"10047_CR116","doi-asserted-by":"publisher","unstructured":"Althumiri NA, Bindhim NF, Al-Rayes SA, Alumran A. A systematic review exploring dietary behaviors, psychological determinants and lifestyle factors associated with weight regain after bariatric surgery. Healthcare (Basel). 2024;12(22). https:\/\/doi.org\/10.3390\/healthcare12222243.","DOI":"10.3390\/healthcare12222243"},{"issue":"3","key":"10047_CR117","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s10865-024-00476-4","volume":"47","author":"CJ Hagerman","year":"2024","unstructured":"Hagerman CJ, Onu MC, Crane NT, Butryn ML, Forman EM. Psychological and behavioral responses to daily weight gain during behavioral weight loss treatment. J Behav Med. 2024;47(3):492\u2013503. https:\/\/doi.org\/10.1007\/s10865-024-00476-4.","journal-title":"J Behav Med"},{"issue":"4","key":"10047_CR118","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/oby.23994","volume":"32","author":"KM Arroyo","year":"2024","unstructured":"Arroyo KM, Carpenter CA, Krukowski RA, Ross KM. Identification of minimum thresholds for dietary self-monitoring to promote weight-loss maintenance. Obesity (Silver Spring). 2024;32(4):655\u20139. https:\/\/doi.org\/10.1002\/oby.23994.","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10047_CR119","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1037\/amp0000521","volume":"75","author":"KA Carr","year":"2020","unstructured":"Carr KA, Epstein LH. Choice is relative: reinforcing value of food and activity in obesity treatment. Am Psychol. 2020;75(2):139\u201351. https:\/\/doi.org\/10.1037\/amp0000521.","journal-title":"Am Psychol"},{"key":"10047_CR120","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12916-015-0323-6","volume":"13","author":"PJ Teixeira","year":"2015","unstructured":"Teixeira PJ, Carra\u00e7a EV, Marques MM, Rutter H, Oppert JM, De Bourdeaudhuij I, et al. Successful behavior change in obesity interventions in adults: a systematic review of self-regulation mediators. BMC Med. 2015;13:84. https:\/\/doi.org\/10.1186\/s12916-015-0323-6.","journal-title":"BMC Med"},{"issue":"7","key":"10047_CR121","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/eat.23509","volume":"54","author":"J Linardon","year":"2021","unstructured":"Linardon J, Tylka TL, Fuller-Tyszkiewicz M. Intuitive eating and its psychological correlates: a meta-analysis. Int J Eat Disord. 2021;54(7):1073\u201398. https:\/\/doi.org\/10.1002\/eat.23509.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"10047_CR122","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s40359-023-01273-5","volume":"11","author":"JE Pyykk\u00f6","year":"2023","unstructured":"Pyykk\u00f6 JE, Hinnen C, Aydin \u00d6, Nieuwdorp M, De Brauw LM, Bruin SC, et al. Attachment style and post-bariatric surgery health behaviours: the mediating role of self-esteem and health self-efficacy. BMC Psychol. 2023;11(1):248. https:\/\/doi.org\/10.1186\/s40359-023-01273-5.","journal-title":"BMC Psychol"},{"issue":"1","key":"10047_CR123","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12916-025-04200-0","volume":"23","author":"H Wu","year":"2025","unstructured":"Wu H, Yang W, Guo T, Cai X, Ji L. Trajectory of the body weight after drug discontinuation in the treatment of anti-obesity medications. BMC Med. 2025;23(1):398. https:\/\/doi.org\/10.1186\/s12916-025-04200-0.","journal-title":"BMC Med"},{"issue":"8","key":"10047_CR124","doi-asserted-by":"publisher","first-page":"e13929","DOI":"10.1111\/obr.13929","volume":"26","author":"S Berg","year":"2025","unstructured":"Berg S, Stickle H, Rose SJ, Nemec EC. Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis. Obes Rev. 2025;26(8):e13929. https:\/\/doi.org\/10.1111\/obr.13929.","journal-title":"Obes Rev"},{"key":"10047_CR125","doi-asserted-by":"publisher","unstructured":"Bannuru RR. Weight stigma and bias: standards of care in overweight and obesity-2025. BMJ Open Diabetes Res Care. 2025;13(Suppl 1). https:\/\/doi.org\/10.1136\/bmjdrc-2025-004962","DOI":"10.1136\/bmjdrc-2025-004962"},{"issue":"12","key":"10047_CR126","doi-asserted-by":"publisher","first-page":"e214182","DOI":"10.1001\/jamahealthforum.2021.4182","volume":"2","author":"LA Eberly","year":"2021","unstructured":"Eberly LA, Yang L, Essien UR, Eneanya ND, Julien HM, Luo J, et al. Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US. JAMA Health Forum. 2021;2(12):e214182. https:\/\/doi.org\/10.1001\/jamahealthforum.2021.4182.","journal-title":"JAMA Health Forum"},{"key":"10047_CR127","doi-asserted-by":"publisher","first-page":"l1476","DOI":"10.1136\/bmj.l1476","volume":"365","author":"B Levis","year":"2019","unstructured":"Levis B, Benedetti A, Thombs BD. Accuracy of patient health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:l1476. https:\/\/doi.org\/10.1136\/bmj.l1476.","journal-title":"BMJ"},{"issue":"6","key":"10047_CR128","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"10047_CR129","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/s0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69\u201377. https:\/\/doi.org\/10.1016\/s0022-3999(01)00296-3.","journal-title":"J Psychosom Res"},{"issue":"3","key":"10047_CR130","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","volume":"67","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67(3):588\u201397. https:\/\/doi.org\/10.1207\/s15327752jpa6703_13.","journal-title":"J Pers Assess"},{"issue":"1","key":"10047_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1751-9861.1999.tb00051.x","volume":"4","author":"GM Timmerman","year":"1999","unstructured":"Timmerman GM. Binge eating scale: further assessment of validity and reliability 1. J Appl Biobehav Res. 1999;4(1):1\u201312.","journal-title":"J Appl Biobehav Res"},{"key":"10047_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eatbeh.2015.03.007","volume":"18","author":"C Duarte","year":"2015","unstructured":"Duarte C, Pinto-Gouveia J, Ferreira C. Expanding binge eating assessment: validity and screening value of the binge eating scale in women from the general population. Eat Behav. 2015;18:41\u20137. https:\/\/doi.org\/10.1016\/j.eatbeh.2015.03.007.","journal-title":"Eat Behav"},{"issue":"4","key":"10047_CR133","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/1098-108X(199412)16:4<363::AID-EAT2260160405>3.0.CO;2-#","volume":"16","author":"CG Fairburn","year":"1994","unstructured":"Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994;16(4):363\u201370.","journal-title":"Int J Eat Disord"},{"issue":"5","key":"10047_CR134","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/oby.2009.321","volume":"18","author":"CM Grilo","year":"2010","unstructured":"Grilo CM, Crosby RD, Peterson CB, Masheb RM, White MA, Crow SJ, et al. Factor structure of the eating disorder examination interview in patients with binge-eating disorder. Obesity. 2010;18(5):977\u201381. https:\/\/doi.org\/10.1038\/oby.2009.321.","journal-title":"Obesity"},{"issue":"3","key":"10047_CR135","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/(sici)1098-108x(199904)25:3<349::aid-eat15>3.0.co;2-m","volume":"25","author":"KH Luce","year":"1999","unstructured":"Luce KH, Crowther JH. The reliability of the eating disorder examination-self-report questionnaire version (EDE-Q). Int J Eat Disord. 1999;25(3):349\u201351. https:\/\/doi.org\/10.1002\/(sici)1098-108x(199904)25:3%3c349::aid-eat15%3e3.0.co;2-m.","journal-title":"Int J Eat Disord"},{"issue":"1","key":"10047_CR136","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40337-022-00604-y","volume":"10","author":"D Spirou","year":"2022","unstructured":"Spirou D, Raman J, Leith M, Collison J, Bishay RH, Ahlenstiel G, et al. The psychometric properties of the grazing questionnaire in an obesity sample with and without binge eating disorder. J Eat Disord. 2022;10(1):82. https:\/\/doi.org\/10.1186\/s40337-022-00604-y.","journal-title":"J Eat Disord"},{"key":"10047_CR137","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.appet.2017.07.012","volume":"117","author":"EM Concei\u00e7\u00e3o","year":"2017","unstructured":"Concei\u00e7\u00e3o EM, Mitchell JE, Machado PPP, Vaz AR, Pinto-Bastos A, Ramalho S, et al. Repetitive eating questionnaire [Rep(eat)-Q]: enlightening the concept of grazing and psychometric properties in a Portuguese sample. Appetite. 2017;117:351\u20138. https:\/\/doi.org\/10.1016\/j.appet.2017.07.012.","journal-title":"Appetite"},{"issue":"6","key":"10047_CR138","first-page":"1231","volume":"6","author":"G Smilkstein","year":"1978","unstructured":"Smilkstein G. The family APGAR: a proposal for a family function test and its use by physicians. J Fam Pract. 1978;6(6):1231\u20139.","journal-title":"J Fam Pract"},{"issue":"3","key":"10047_CR139","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s1740-1445(03)00023-8","volume":"1","author":"TF Cash","year":"2004","unstructured":"Cash TF, Jakatdar TA, Williams EF. The body image quality of life inventory: further validation with college men and women. Body Image. 2004;1(3):279\u201387. https:\/\/doi.org\/10.1016\/s1740-1445(03)00023-8.","journal-title":"Body Image"},{"issue":"8","key":"10047_CR140","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JPH Wilding","year":"2022","unstructured":"Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553\u201364. https:\/\/doi.org\/10.1111\/dom.14725.","journal-title":"Diabetes Obes Metab"},{"issue":"17","key":"10047_CR141","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","volume":"365","author":"P Sumithran","year":"2011","unstructured":"Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597\u2013604. https:\/\/doi.org\/10.1056\/NEJMoa1105816.","journal-title":"N Engl J Med"},{"key":"10047_CR142","doi-asserted-by":"publisher","first-page":"102475","DOI":"10.1016\/j.eclinm.2024.102475","volume":"69","author":"SBK Jensen","year":"2024","unstructured":"Jensen SBK, Blond MB, Sandsdal RM, Olsen LM, Juhl CR, Lundgren JR, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial. EClinicalMedicine. 2024;69:102475. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102475.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10047_CR143","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1146\/annurev-clinpsy-080822-043256","volume":"20","author":"CM Grilo","year":"2024","unstructured":"Grilo CM. Treatment of eating disorders: current status, challenges, and future directions. Annu Rev Clin Psychol. 2024;20(1):97\u2013123. https:\/\/doi.org\/10.1146\/annurev-clinpsy-080822-043256.","journal-title":"Annu Rev Clin Psychol"},{"key":"10047_CR144","doi-asserted-by":"publisher","unstructured":"Arillotta D, Floresta G, Guirguis A, Corkery JM, Catalani V, Martinotti G, et al. GLP-1 Receptor agonists and related mental health issues; insights from a range of social media platforms using a mixed-methods approach. Brain Sci. 2023;13(11). https:\/\/doi.org\/10.3390\/brainsci13111503.","DOI":"10.3390\/brainsci13111503"},{"issue":"5","key":"10047_CR145","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.orcp.2019.07.003","volume":"13","author":"S Sockalingam","year":"2019","unstructured":"Sockalingam S, Leung SE, Hawa R, Wnuk S, Parikh SV, Jackson T, et al. Telephone-based cognitive behavioural therapy for female patients 1-year post-bariatric surgery: a pilot study. Obes Res Clin Pract. 2019;13(5):499\u2013504. https:\/\/doi.org\/10.1016\/j.orcp.2019.07.003.","journal-title":"Obes Res Clin Pract"},{"issue":"6","key":"10047_CR146","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1159\/000539797","volume":"17","author":"T Lau","year":"2024","unstructured":"Lau T, Schild S, Klos B, Schraml J, Archid R, Stengel A, et al. Psychological benefits of a preoperative educational bridging program for bariatric surgery: does face-to-face versus videoconference-based delivery make a difference? Obes Facts. 2024;17(6):553\u201369. https:\/\/doi.org\/10.1159\/000539797.","journal-title":"Obes Facts"},{"issue":"3","key":"10047_CR147","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41366-024-01599-z","volume":"49","author":"D Anazco","year":"2025","unstructured":"Anazco D, Acosta A. Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy. Int J Obes (Lond). 2025;49(3):452\u201363. https:\/\/doi.org\/10.1038\/s41366-024-01599-z.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"10047_CR148","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s44220-025-00390-x","volume":"3","author":"R De Giorgi","year":"2025","unstructured":"De Giorgi R, Ghenciulescu A, Dziwisz O, Taquet M, Adler AI, Koychev I, et al. An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders. Nat Ment Health. 2025;3(3):354\u201373. https:\/\/doi.org\/10.1038\/s44220-025-00390-x.","journal-title":"Nat Ment Health"},{"issue":"Pt 1","key":"10047_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1348\/135910709x466063","volume":"15","author":"KE Heron","year":"2010","unstructured":"Heron KE, Smyth JM. Ecological momentary interventions: incorporating mobile technology into psychosocial and health behaviour treatments. Br J Health Psychol. 2010;15(Pt 1):1\u201339. https:\/\/doi.org\/10.1348\/135910709x466063.","journal-title":"Br J Health Psychol"},{"issue":"9","key":"10047_CR150","doi-asserted-by":"publisher","first-page":"e13596","DOI":"10.1111\/obr.13596","volume":"24","author":"M Randle","year":"2023","unstructured":"Randle M, Ahern AL, Boyland E, Christiansen P, Halford JCG, Stevenson-Smith J, et al. A systematic review of ecological momentary assessment studies of appetite and affect in the experience of temptations and lapses during weight loss dieting. Obes Rev. 2023;24(9):e13596. https:\/\/doi.org\/10.1111\/obr.13596.","journal-title":"Obes Rev"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10047-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-026-10047-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-026-10047-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T06:24:43Z","timestamp":1777703083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-026-10047-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,2]]},"references-count":150,"alternative-id":["10047"],"URL":"https:\/\/doi.org\/10.1007\/s11154-026-10047-4","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,2]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Birkenfeld reports that his department at University Hospital T\u00fcbingen has received research support from AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Novo Nordisk.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}